
    
      One hundred and thirty patients were enrolled and there two sides of nasolabial folds (NLF)
      were randomized to receive HA with lidocaine or HA. The primary outcome was immediate visual
      analogue scale (VAS) of pain evaluated after injection for both NLF sides. Secondary outcomes
      including VAS pain, wrinkle severity rating scale (WSRS), global aesthetic improvement scale
      (GAIS) and AE were observed at 1, 3, 6, 9, 12 follow-ups.
    
  